Literature DB >> 30617222

IRAK-M Associates with Susceptibility to Adult-Onset Asthma and Promotes Chronic Airway Inflammation.

Yi Liu1,2, Mingqiang Zhang1, Lili Lou1, Lun Li1, Youming Zhang3, Wei Chen4, Weixun Zhou5, Yan Bai6, Jinming Gao7.   

Abstract

IL-1R-associated kinase (IRAK)-M regulates lung immunity during asthmatic airway inflammation. However, the regulatory effect of IRAK-M differs when airway inflammation persists. A positive association between IRAK-M polymorphisms with childhood asthma has been reported. In this study, we investigated the role of IRAK-M in the susceptibility to adult-onset asthma and in chronic airway inflammation using an animal model. Through genetic analysis of IRAK-M polymorphisms in a cohort of adult-onset asthma patients of Chinese Han ethnicity, we identified two IRAK-M single nucleotide polymorphisms, rs1624395 and rs1370128, genetically associated with adult-onset asthma. Functionally, the top-associated rs1624395, with an enhanced affinity to the transcription factor c-Jun, was associated with a higher expression of IRAK-M mRNA in blood monocytes. In contrast to the protective effect of IRAK-M in acute asthmatic inflammation, we found a provoking impact of IRAK-M on chronic asthmatic inflammation. Following chronic OVA stimulation, IRAK-M knockout (KO) mice presented with significantly less inflammatory cells, a lower Th2 cytokine level, a higher IFN-γ concentration, and increased percentage of Th1 cells in the lung tissue than wild type mice. Moreover, lung dendritic cells (DC) from OVA-treated IRAK-M KO mice expressed a higher percentage of costimulatory molecules PD-L1 and PD-L2. Mechanistically, in vitro TLR ligation led to a greater IFN-γ production by IRAK-M KO DCs than wild type DCs. These findings demonstrated a distinctive role of IRAK-M in maintaining chronic Th2 airway inflammation via inhibiting the DC-mediated Th1 activation and indicated a complex role for IRAK-M in the initiation and progression of experimental allergic asthma.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30617222      PMCID: PMC6344301          DOI: 10.4049/jimmunol.1800712

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  Chromosome 12q harbors multiple genetic loci related to asthma and asthma-related phenotypes.

Authors:  Benjamin A Raby; Edwin K Silverman; Ross Lazarus; Christoph Lange; David J Kwiatkowski; Scott T Weiss
Journal:  Hum Mol Genet       Date:  2003-08-15       Impact factor: 6.150

Review 2.  Role of PD-L1 and PD-L2 in allergic diseases and asthma.

Authors:  A K Singh; P Stock; O Akbari
Journal:  Allergy       Date:  2010-08-17       Impact factor: 13.146

3.  Potential etiologic and functional implications of genome-wide association loci for human diseases and traits.

Authors:  Lucia A Hindorff; Praveen Sethupathy; Heather A Junkins; Erin M Ramos; Jayashri P Mehta; Francis S Collins; Teri A Manolio
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-27       Impact factor: 11.205

4.  The role of CTLA-4 in regulating Th2 differentiation.

Authors:  M A Oosterwegel; D A Mandelbrot; S D Boyd; R B Lorsbach; D Y Jarrett; A K Abbas; A H Sharpe
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

Review 5.  Dendritic cell and epithelial cell interactions at the origin of murine asthma.

Authors:  Bart N Lambrecht; Hamida Hammad
Journal:  Ann Am Thorac Soc       Date:  2014-12

6.  Critical Role of IRAK-M in Regulating Antigen-Induced Airway Inflammation.

Authors:  Mingqiang Zhang; Wei Chen; Weixun Zhou; Yan Bai; Jinming Gao
Journal:  Am J Respir Cell Mol Biol       Date:  2017-11       Impact factor: 6.914

7.  IRAK-M removal counteracts dendritic cell vaccine deficits in migration and longevity.

Authors:  Meghan E Turnis; Xiao-Tong Song; Adham Bear; Aaron E Foster; Stephen Gottschalk; Malcolm K Brenner; Si-Yi Chen; Cliona M Rooney
Journal:  J Immunol       Date:  2010-09-03       Impact factor: 5.422

8.  B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanism.

Authors:  Koichiro Matsumoto; Hiromasa Inoue; Takako Nakano; Miyuki Tsuda; Yuki Yoshiura; Satoru Fukuyama; Fumihiko Tsushima; Tomoaki Hoshino; Hisamichi Aizawa; Hisaya Akiba; Drew Pardoll; Nobuyuki Hara; Hideo Yagita; Miyuki Azuma; Yoichi Nakanishi
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

Review 9.  Genetic and genomic approaches to asthma: new insights for the origins.

Authors:  Youming Zhang; Miriam F Moffatt; William O C Cookson
Journal:  Curr Opin Pulm Med       Date:  2012-01       Impact factor: 3.155

10.  Effect of IRAK-M on Airway Inflammation Induced by Cigarette Smoking.

Authors:  Haihong Gong; Tao Liu; Wei Chen; Weixun Zhou; Jinming Gao
Journal:  Mediators Inflamm       Date:  2017-08-29       Impact factor: 4.711

View more
  4 in total

1.  MicroRNA-490-3p inhibits inflammatory responses in LPS-induced acute lung injury of neonatal rats by suppressing the IRAK1/TRAF6 pathway.

Authors:  Guang Yang; Yuan Zhao
Journal:  Exp Ther Med       Date:  2020-12-17       Impact factor: 2.447

2.  IRAK-M knockout promotes allergic airway inflammation, but not airway hyperresponsiveness, in house dust mite-induced experimental asthma model.

Authors:  Xudong Zhang; Mingqiang Zhang; Lun Li; Wei Chen; Wexun Zhou; Jinming Gao
Journal:  J Thorac Dis       Date:  2021-03       Impact factor: 2.895

3.  A systematic review and meta-analyses of interleukin-1 receptor associated kinase 3 (IRAK3) action on inflammation in in vivo models for the study of sepsis.

Authors:  Trang H Nguyen; Ilona Turek; Terri Meehan-Andrews; Anita Zacharias; Helen R Irving
Journal:  PLoS One       Date:  2022-02-15       Impact factor: 3.240

4.  Fatty acid-binding protein 5 limits ILC2-mediated allergic lung inflammation in a murine asthma model.

Authors:  Shuhei Kobayashi; Shunichi Tayama; Hai The Phung; Yoshiteru Kagawa; Hirofumi Miyazaki; Yu Takahashi; Takashi Maruyama; Naoto Ishii; Yuji Owada
Journal:  Sci Rep       Date:  2020-10-06       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.